Clinical Trials Directory

Trials / Completed

CompletedNCT02022670

Sodium Nitrite to Treat Arterial Aging

Clinical Translation of Nitrite Therapy to Treat Arterial Aging in Humans

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Colorado, Boulder · Academic / Other
Sex
All
Age
50 Years – 79 Years
Healthy volunteers
Accepted

Summary

The proposed research will determine the effectiveness of nitrite, a naturally occurring compound in the body, for improving the health and function of arteries in middle-aged and older adults. The study also will provide insight into how sodium nitrite therapy improves artery health by determining the physiological mechanisms (biological reasons) involved. Overall, the proposed research will provide important new scientific evidence on the effectiveness of sodium nitrite for decreasing the risk of developing cardiovascular diseases with aging.

Detailed description

The improvement in blood vessel function and stiffness will be determined over a 10 week period. Subjects will be randomly assigned to either placebo (0 mg/day), low dose (80 mg/day) or high dose (160 mg/day) sodium nitrite. Main outcome measures will be performed at baseline and week 10.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboSugar pill manufactured to mimic sodium nitrite capsules
DRUGSodium Nitrite80 mg/d or 160 mg/d

Timeline

Start date
2011-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-12-30
Last updated
2015-07-15
Results posted
2015-06-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02022670. Inclusion in this directory is not an endorsement.